Clinical trial
Multicentre, Unblinded, Open Label, Randomised, Controlled Trial to Assess the Effect of Augmented Vs. Normal Continuous Renal Replacement Therapy (CRRT) on 90-Day All-Cause Mortality of Intensive Care Unit Patients With Severe Acute Renal Failure (ARF).
NCT00221013 is registered in ClinicalTrials.gov with The George Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicentre, Unblinded, Open Label, Randomised, Controlled Trial to Assess the Effect of Augmented Vs. Normal Continuous Renal Replacement Therapy (CRRT) on 90-Day All-Cause Mortality of Intensive Care Unit Patients With Severe Acute Renal Failure (ARF).
- Lead sponsor
- The George Institute
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2005
- Completion date
- January 31, 2009
- Enrollment
- 1,508 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute renal failure